( April 4, 2025, 11:57 AM EDT) -- FORT WORTH, Texas — The U.S. Food and Drug Administration violated federal law when it “abruptly declared the shortage” of tirzepatide, an FDA-approved drug for diabetes and weight loss, over and removed the drug from the agency’s drug shortage list, companies representing the interests of drug compounders tell a Texas federal court in an April 3 motion, moving for summary judgment on its claims against the FDA....